Kavya Gopal is the current chair of the British Biosimilars Association (BBA) as well as Head of the Specialty Business for Sandoz UK. She has nearly 20 years of experience in the pharmaceutical industry leading successful teams in the US and in global roles for Novartis/Sandoz before moving to the UK earlier this year.
She began her career in commercial analytics at GlaxoWellcome and has worked across multiple therapy areas in marketing, sales, operations and strategy. Her breadth of expertise covers originator pharmaceuticals and generic medicines, including a deep knowledge of biosimilars. Kavyamholds a degree in Chemistry from UNC-Chapel Hill and an MBA from INSEAD.